Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-05, Stock:LLY, The news for the past five days is as follows:
2019-05-29: NEWS1: 5 Pharmaceutical Stocks With Big Moats and Bridges.NEWS2: Lilly Announces Webcast to Discuss ADA Presentations and Diabetes Portfolio.NEWS3: Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate.NEWS4: Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate.NEWS5: 3 Big Stock Charts for Wednesday: Juniper Networks, Eli Lilly and Hormel Foods.NEWS6: 3 Big Stock Charts for Wednesday: Juniper Networks, Eli Lilly and Hormel Foods.NEWS7: Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate.NEWS8: Pro-choice groups lost in Alabama despite outspending the pro-life side by 100-to-1.NEWS9: Bayer to work with Foundation Medicine on selecting cancer patients.NEWS10: 3 Big Stock Charts for Wednesday: Juniper Networks, Eli Lilly and Hormel Foods.
2019-05-30: NEWS1: Lilly to Participate in Goldman Sachs Global Healthcare Conference.NEWS2: Lilly (LLY) Down 2.3% Since Last Earnings Report: Can It Rebound?.NEWS3: Lilly (LLY) Down 2.3% Since Last Earnings Report: Can It Rebound?.NEWS4: Lilly (LLY) Down 2.3% Since Last Earnings Report: Can It Rebound?.NEWS5: See what the IHS Markit Score report has to say about Eli Lilly and Co..
2019-05-31: NEWS1: After Hours Most Active for May 31, 2019 :  SAN, BAC, VER, LLY, ETR, XOM.NEWS2: After Hours Most Active for May 31, 2019 :  SAN, BAC, VER, LLY, ETR, XOM.NEWS3: Hurricane Season is Almost Here. Are You Ready?.
2019-06-03: NEWS1: Why Cancer-Fighting Stocks & ETFs Are Soaring.NEWS2: Why Cancer-Fighting Stocks & ETFs Are Soaring.NEWS3: Why Cancer-Fighting Stocks & ETFs Are Soaring.NEWS4: Here's Why Mirati Therapeutics Is Jumping Today.NEWS5: Here's Why Mirati Therapeutics Is Jumping Today.NEWS6: Merck's Keytruda Improves 5-Year Survival in Lung Cancer.NEWS7: Merck's Keytruda Improves 5-Year Survival in Lung Cancer.NEWS8: Merck's Keytruda Improves 5-Year Survival in Lung Cancer.
2019-06-04: NEWS1: FDA approves Lilly's migraine drug as first ever cluster headache treatment.NEWS2: Notable ETF Inflow Detected - VV, ACN, NKE, LLY.NEWS3: Notable ETF Inflow Detected - VV, ACN, NKE, LLY.NEWS4: Celldex Presents Data From CDX-3379 Study at ASCO, Stock Down.NEWS5: Celldex Presents Data From CDX-3379 Study at ASCO, Stock Down.NEWS6: 3 Cancer Stocks Given a Lift by Amgen.NEWS7: 3 Cancer Stocks Given a Lift by Amgen.NEWS8: Celldex Presents Data From CDX-3379 Study at ASCO, Stock Down.NEWS9: 3 Cancer Stocks Given a Lift by Amgen.NEWS10: U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes.

Answer: Decrease